Loading organizations...
Loading organizations...
Developing enzyme-based therapies and diagnostics for Alzheimer's disease.
PAM Theragnostics has raised $1.7M across 1 funding round.
PAM Theragnostics has raised $1.7M in total across 1 funding round.
PAM Theragnostics has raised $1.7M in total across 1 funding round.
PAM Theragnostics's investors include Nam Nguyen.
PAM Theragnostics has raised $1.7M across 1 funding round. Most recently, it raised $1.7M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 18, 2022 | $1.7M Series A | Nam Nguyen |